A Study of Flt3-Ligand Levels in Sjögrens Syndrome

Göteborg University30 enrolled

Overview

The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sjogrens Syndrome

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * fulfill the ACR-criteria for primary Sjogrens syndrome, * age above 18 years old Exclusion Criteria: * other CNS-disease

Locations (1)

Dept of Rheumatology, Sahlgrenska University Hospital

Gothenburg, Sweden

Outcomes

Primary Outcomes

Correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome

Time frame: June 2009 - June 2015

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.